Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome.

Diabetes Care · 2008 · PMC2494658 · PMID 18509206

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

failed to reach statistical significanceP = 0.08so close (0.05 < p ≤ 0.1)

The fall in VLDL apoC-III concentration was associated with the increase in VLDL apoC-III FCR, but this failed to reach statistical significance ( r = −0.511, P = 0.08).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.